RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

Triple-negative breast cancer (TNBC) stands out as the most aggressive subtype within the spectrum of breast cancer. The current clinical guidelines propose treatment strategies involving cytotoxic agents like epirubicin or paclitaxel. However, the emergence of acquired resistance frequently precipi...

Description complète

Détails bibliographiques
Auteurs principaux:	Fengxu Lv, Wentao Si, Xiaodan Xu, Xiaogang He, Ying Wang, Yetian Li, Feifei Li
Format:	Article
Langue:	English
Publié:	Elsevier 2024-02-01
Collection:	Neoplasia: An International Journal for Oncology Research
Sujets:	Triple negative breast cancer Chemoresistance Cancer stem cells RUNX2 TGF-β
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S1476558624000046

Documents similaires

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
par: Wentao Si, et autres
Publié: (2022-11-01)

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
par: Natalia B. Fernández, et autres
Publié: (2023-01-01)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
par: Bradley A. Hancock, et autres
Publié: (2019-08-01)

Comprehensive Analysis of RUNX and TGF-β Mediated Regulation of Immune Cell Infiltration in Breast Cancer
par: Liang Gao, et autres
Publié: (2021-08-01)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
par: Guoyu Wu, et autres
Publié: (2022-04-01)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
par: Alexander H. Chung, et autres
Publié: (2019-02-01)

DNA methylation affects metastasis of renal cancer and is associated with TGF-β/RUNX3 inhibition
par: Jianbo Zheng, et autres
Publié: (2018-04-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
par: Meng Wang, et autres
Publié: (2021-10-01)

Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
par: Anuradha Illendula, et autres
Publié: (2016-06-01)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
par: Margarite D. Matossian, et autres
Publié: (2019-03-01)

Data mining analysis of miR-638 and key genes interaction in cisplatin resistant triple-negative breast cancer
par: Adam Hermawan, et autres
Publié: (2019-12-01)

The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
par: Adiba S. Khan, et autres
Publié: (2023-02-01)

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
par: Shen-Jun Yuan, et autres
Publié: (2019-10-01)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
par: Ling Wang, et autres
Publié: (2018-07-01)

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
par: Hitesh Kumar, et autres
Publié: (2023-12-01)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
par: Liu C, et autres
Publié: (2020-12-01)

A clinicopathologic study of triple negative breast cancer
par: Vandana L Gaopande, et autres
Publié: (2015-01-01)

IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
par: Nicholas R. Hum, et autres
Publié: (2022-07-01)

Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
par: Andrew Sulaiman, et autres
Publié: (2021-10-01)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
par: Alaa M. Ghallab, et autres
Publié: (2022-04-01)

Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer
par: Lei Di, et autres
Publié: (2019-03-01)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
par: Weiguang Liu, et autres
Publié: (2019-09-01)

RUNX regulated immune-associated genes predicts prognosis in breast cancer
par: Jingyue Fu, et autres
Publié: (2022-08-01)

M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer
par: Xi Liu, et autres
Publié: (2024-02-01)

CD74-AKT Axis Is a Potential Therapeutic Target in Triple-Negative Breast Cancer
par: Jingchao Wang, et autres
Publié: (2024-06-01)

Role of eIF4A1 in triple‐negative breast cancer stem‐like cell‐mediated drug resistance
par: Dayanidhi Raman, et autres
Publié: (2022-12-01)

Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines
par: Ammar Said Suliman, et autres
Publié: (2021-01-01)

Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
par: Yen-Dun Tony Tzeng, et autres
Publié: (2018-11-01)

TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
par: Weiguang Liu, et autres
Publié: (2019-07-01)

Current approaches in treatment of triple-negative breast cancer
par: Hanan Ahmed Wahba, et autres
Publié: (2015-06-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
par: Mahdi Aghili, et autres
Publié: (2013-08-01)

Platinum chemotherapy for early triple-negative breast cancer
par: Sofia RE. Mason, et autres
Publié: (2024-06-01)

Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
par: Srijan Basu, et autres
Publié: (2023-11-01)

Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
par: Omran Saifi, et autres
Publié: (2022-04-01)

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
par: Yueh-Te Lin, et autres
Publié: (2022-10-01)

Immunotherapy Treatment for Triple Negative Breast Cancer
par: Elizabeth R. Berger, et autres
Publié: (2021-08-01)

Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer
par: Magdalena Niedolistek, et autres
Publié: (2020-04-01)

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
par: Lisa Agnello, et autres
Publié: (2023-07-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
par: Mohammed Amrallah A., et autres
Publié: (2021-05-01)

The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer
par: Yi-Fen Chiang, et autres
Publié: (2023-01-01)